Search research articles
Contact Us
Filters
Showing results (111-120 of 169) with videos related to
Page
of 17
Sort By:
Blood
|
February 27, 2013
A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenance
Fabio Santoro, Oronza A Botrugno, Roberto Dal Zuffo, et al.
Journal of Medicinal Chemistry
|
December 26, 2015
Discovery of a Novel Inhibitor of Histone Lysine-Specific Demethylase 1A (KDM1A/LSD1) as Orally Active Antitumor Agent
Paola Vianello, Oronza A Botrugno, Anna Cappa, et al.
The Journal of Biological Chemistry
|
June 14, 2003
Activation of protein kinase C delta by all-trans-retinoic acid
Suman Kambhampati, Yongzhong Li, Amit Verma, et al.
Nature Cell Biology
|
February 22, 2011
Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer
Raffaella Di Micco, Gabriele Sulli, Miryana Dobreva, et al.
European Journal of Medicinal Chemistry
|
January 21, 2019
Rad51/BRCA2 disruptors inhibit homologous recombination and synergize with olaparib in pancreatic cancer cells
Marinella Roberti, Fabrizio Schipani, Greta Bagnolini, et al.
European Journal of Medicinal Chemistry
|
March 14, 2015
Pure enantiomers of benzoylamino-tranylcypromine: LSD1 inhibition, gene modulation in human leukemia cells and effects on clonogenic potential of murine promyelocytic blasts
Sergio Valente, Veronica Rodriguez, Ciro Mercurio, et al.
Science Advances
|
April 15, 2020
Targeting the scaffolding role of LSD1 (KDM1A) poises acute myeloid leukemia cells for retinoic acid-induced differentiation
Roberto Ravasio, Elena Ceccacci, Luciano Nicosia, et al.
Nature Communications
|
October 1, 2025
A histone-centric multi-omics study shows that increased H3K4 methylation sustains triple-negative breast cancer phenotypes
Roberta Noberini, Giulia Robusti, Alessandro Vai, et al.
Blood
|
October 9, 2015
Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies
Geoffrey M Matthews, Parinaz Mehdipour, Leonie A Cluse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 1, 2016
c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in Cancer
Angela Nebbioso, Vincenzo Carafa, Mariarosaria Conte, et al.
Page
of 17
Search research articles
Search
Showing results (111-120 of 169) with videos related to
Sort By:
Page
of 17
Blood
|
February 27, 2013
A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenance
Fabio Santoro, Oronza A Botrugno, Roberto Dal Zuffo, et al.
Journal of Medicinal Chemistry
|
December 26, 2015
Discovery of a Novel Inhibitor of Histone Lysine-Specific Demethylase 1A (KDM1A/LSD1) as Orally Active Antitumor Agent
Paola Vianello, Oronza A Botrugno, Anna Cappa, et al.
The Journal of Biological Chemistry
|
June 14, 2003
Activation of protein kinase C delta by all-trans-retinoic acid
Suman Kambhampati, Yongzhong Li, Amit Verma, et al.
Nature Cell Biology
|
February 22, 2011
Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer
Raffaella Di Micco, Gabriele Sulli, Miryana Dobreva, et al.
European Journal of Medicinal Chemistry
|
January 21, 2019
Rad51/BRCA2 disruptors inhibit homologous recombination and synergize with olaparib in pancreatic cancer cells
Marinella Roberti, Fabrizio Schipani, Greta Bagnolini, et al.
European Journal of Medicinal Chemistry
|
March 14, 2015
Pure enantiomers of benzoylamino-tranylcypromine: LSD1 inhibition, gene modulation in human leukemia cells and effects on clonogenic potential of murine promyelocytic blasts
Sergio Valente, Veronica Rodriguez, Ciro Mercurio, et al.
Science Advances
|
April 15, 2020
Targeting the scaffolding role of LSD1 (KDM1A) poises acute myeloid leukemia cells for retinoic acid-induced differentiation
Roberto Ravasio, Elena Ceccacci, Luciano Nicosia, et al.
Nature Communications
|
October 1, 2025
A histone-centric multi-omics study shows that increased H3K4 methylation sustains triple-negative breast cancer phenotypes
Roberta Noberini, Giulia Robusti, Alessandro Vai, et al.
Blood
|
October 9, 2015
Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies
Geoffrey M Matthews, Parinaz Mehdipour, Leonie A Cluse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 1, 2016
c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in Cancer
Angela Nebbioso, Vincenzo Carafa, Mariarosaria Conte, et al.
Page
of 17